CERRI, MICHAELA
 Distribuzione geografica
Continente #
EU - Europa 328
NA - Nord America 295
AS - Asia 75
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
SA - Sud America 1
Totale 704
Nazione #
US - Stati Uniti d'America 293
IE - Irlanda 104
DE - Germania 67
SE - Svezia 57
UA - Ucraina 36
IT - Italia 33
CN - Cina 30
FI - Finlandia 17
IN - India 16
HK - Hong Kong 14
SG - Singapore 10
EU - Europa 4
GB - Regno Unito 4
FR - Francia 3
IR - Iran 3
BG - Bulgaria 2
CA - Canada 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 704
Città #
Dublin 104
Jacksonville 71
Dearborn 30
Wilmington 27
Chandler 22
Piemonte 15
Hong Kong 14
Lawrence 12
Princeton 12
Beijing 9
Boardman 8
Bremen 6
San Mateo 6
Singapore 6
Ann Arbor 4
Ashburn 4
Florence 4
Grafing 4
Andover 3
Guangzhou 3
Hefei 3
Asti 2
Berlin 2
Düsseldorf 2
Houston 2
Kunming 2
Leawood 2
Nanjing 2
Norwalk 2
Winnipeg 2
Zhengzhou 2
Cardano 1
Colle 1
Fairfield 1
Fuzhou 1
Grafenhausen 1
Gunzenhausen 1
Hanover 1
Jakarta 1
Jinan 1
Kemerovo 1
Köln 1
Milan 1
Munich 1
Naaldwijk 1
New York 1
Nice 1
Ningbo 1
Novara 1
Palmetto 1
Redwood City 1
Rome 1
Seattle 1
Shaoxing 1
Shenyang 1
Storrs Mansfield 1
Taiyuan 1
Teruel 1
Torino 1
Valdagno 1
Zanjan 1
Totale 417
Nome #
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 74
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 69
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 68
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 68
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 64
The genetics of nodal marginal zone lymphoma 63
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 61
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 55
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 55
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 52
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 51
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 48
Totale 728
Categoria #
all - tutte 3.317
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020156 2 0 14 0 23 16 30 15 16 28 12 0
2020/202182 16 0 12 2 11 1 12 3 13 0 12 0
2021/202281 0 0 6 10 7 0 6 1 10 7 14 20
2022/2023215 12 11 22 0 11 14 7 14 109 0 10 5
2023/202479 8 7 5 3 14 1 13 2 0 1 2 23
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 728